Two Chinese drugmakers have announced that a blood-pressure medication they exported to Taiwan contained a potentially cancer-causing impurity.
This occurs a month after the same problem at another Chinese manufacturer prompted a global recall.
Tianyu Pharm and Rundu Pharma said batches of valsartan
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
